Skip to main content

Table 1 The baseline information of patients with colorectal cancer (CRC) and scoring interferon regulatory factor (IRF) family by random forest algorithm from The Cancer Genome Atlas (TCGA) database of COAD/READ datasets

From: Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer

Patients from COAD/READ

All patients

(n = 597)

Low

(n = 298)

High

(n = 299)

P value

Gender

   

0.904

 Female

277 (46.4%)

139 (46.6%)

138 (46.2%)

 

 Male

320 (53.6%)

159 (53.4%)

161 (53.8%)

 

Age

   

0.378

 < 60

170 (28.5%)

80 (26.8%)

90 (30.1%)

 

 ≥ 60

427 (71.5%)

218 (73.2%)

209 (69.9%)

 

Pathologic stage

   

 < 0.001

 I

108 (18.1%)

69 (23.1%)

39 (13.1%)

 

 II

225 (37.7%)

120 (40.3%)

105 (35.1%)

 

 III

177 (29.6%)

86 (28.9%)

91 (30.4%)

 

 IV

87 (14.6%)

23 (7.7%)

64 (21.4%)

 

T

   

0.002

 T1

19 (3.2%)

11 (3.7%)

8 (2.7%)

 

 T2

105 (17.6%)

65 (21.8%)

40 (13.4%)

 

 T3

408 (68.3%)

201 (67.5%)

207 (69.2%)

 

 T4

65 (10.9%)

21 (7.0%)

44 (14.7%)

 

N

   

 < 0.001

 N0

342 (57.3%)

191 (64.1%)

151 (50.6%)

 

 N1

145 (24.3%)

71 (23.8%)

74 (24.7%)

 

 N2

110 (18.4%)

36 (12.1%)

74 (24.7%)

 

M

   

 < 0.001

 M0

453 (75.9%)

249 (83.6%)

204 (68.2%)

 

 M1

85 (14.2%)

22 (7.4%)

63 (21.1%)

 

 MX

59 (9.9%)

27 (9.0%)

32 (10.7%)

Â